Paul Bisaro, Director at MYRIAD GENETICS INC (MYGN), bought 7,500 shares at $3.69 ($28K) on 2026-05-14, disclosed to the SEC on 2026-05-14.
Director Paul Bisaro purchased 7,500 shares at $3.69, marking the largest insider purchase in the company's history. This move comes as the stock trades near its 52-week low, potentially signaling confidence in a value play.
The stock is currently trading at $3.63, down 26.37% over the last 30 days and sitting at the exact level of its 52-week low. This represents a 57.74% decline from the 52-week high of $8.59.
Something here stands out, but not much.
| Filing → |
| TXMD | BUY | 2021-08-18 | $40K | — | Filing → |
| TXMD | BUY | 2020-06-08 | $114K | — | Filing → |
| AMRX | BUY | 2019-03-12 | $203K | — | Filing → |